v3.26.1
Earnings per share - Narrative (Details) - shares
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Stock options    
Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]    
Number of potential ordinary shares that are antidilutive in period presented 0 37,520